The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.
An F.D.A. spokeswoman declined to comment.
The agency had recently set an unofficial deadline for approval of around Labor Day.
READ FULL ARTICLE HERE AT THE NEW YORK TIMES: